Literature DB >> 28084580

Vasculogenic Mimicry in Clinically Non-functioning Pituitary Adenomas: a Histologic Study.

Joseph Di Michele1, Fabio Rotondo2, Kalman Kovacs3, Luis V Syro4, George M Yousef3, Michael D Cusimano1, Antonio Di Ieva5,6.   

Abstract

The term "vasculogenic mimicry" (VM) refers to the phenomenon in which vascular-like channels, which are not lined by endothelial cells, are formed in tumors. Since its discovery in 1999, it has been observed in several tumor types and is proposed to provide blood perfusion to tumors in absence of co-apted or neo-angiogenic blood vessels. Pituitary tumors are generally slow growing, benign adenomas which are less vascularized than the normal pituitary gland. To date, VM in pituitary adenomas has not been described. In this histological study, we assessed the presence of VM in a series of surgically resected clinically non-functioning pituitary adenomas (NFPAs) using CD34 and Periodic Acid-Schiff (PAS) double staining. To identify VM, slides were assessed for the presence of CD34-negative and PAS-positive channels indicating that they were not lined by endothelial cells. The histological staining pattern suggestive of VM was noted in 22/49 (44.9%) of the specimens studied. VM was observed in both recurring and non-recurring NFPAs. The incidence of VM present varied from case to case and within groups. There was no association between the presence of VM and gender, tumor size, Ki-67 index, recurrence or cavernous sinus invasion. VM was not noted in cases of non-tumorous pituitaries. Our findings suggest the existence of a complementary perfusion system in pituitary adenomas, implying potential clinical implications with respect to response to therapy and clinical course. Further research is warranted to confirm the presence of VM in pituitary adenomas to elucidate its clinical relevance in patients diagnosed with a pituitary adenoma.

Entities:  

Keywords:  Biomarkers; Microvascularity; Pathology; Pituitary adenoma; Vasculogenic mimicry

Mesh:

Year:  2017        PMID: 28084580     DOI: 10.1007/s12253-017-0196-4

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  43 in total

Review 1.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

2.  Melanoma spheroid formation involves laminin-associated vasculogenic mimicry.

Authors:  Allison R Larson; Chung-Wei Lee; Cecilia Lezcano; Qian Zhan; John Huang; Andrew H Fischer; George F Murphy
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

Review 3.  To sprout or to split? VEGF, Notch and vascular morphogenesis.

Authors:  Roberto Gianni-Barrera; Marianna Trani; Silvia Reginato; Andrea Banfi
Journal:  Biochem Soc Trans       Date:  2011-12       Impact factor: 5.407

4.  Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis.

Authors:  J P Yang; Y D Liao; D M Mai; P Xie; Y Y Qiang; L S Zheng; M Y Wang; Y Mei; D F Meng; L Xu; L Cao; Q Yang; X X Yang; W B Wang; L X Peng; B J Huang; C N Qian
Journal:  Angiogenesis       Date:  2016-02-22       Impact factor: 9.596

5.  Angiogenesis in pituitary adenomas and the normal pituitary gland.

Authors:  H E Turner; Z Nagy; K C Gatter; M M Esiri; A L Harris; J A Wass
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

6.  Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin.

Authors:  Federica Ruffini; Grazia Graziani; Lauretta Levati; Lucio Tentori; Stefania D'Atri; Pedro M Lacal
Journal:  Int J Cancer       Date:  2014-11-28       Impact factor: 7.396

Review 7.  Aggressive pituitary adenomas--diagnosis and emerging treatments.

Authors:  Antonio Di Ieva; Fabio Rotondo; Luis V Syro; Michael D Cusimano; Kalman Kovacs
Journal:  Nat Rev Endocrinol       Date:  2014-05-13       Impact factor: 43.330

8.  Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors.

Authors:  Baocun Sun; Shuo Qie; Shiwu Zhang; Tao Sun; Xiulan Zhao; Songyuan Gao; Chunsheng Ni; Xinghui Wang; Yanxue Liu; Lihua Zhang
Journal:  Hum Pathol       Date:  2008-03       Impact factor: 3.466

Review 9.  Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?

Authors:  Tom Donnem; Jiangting Hu; Mary Ferguson; Omanma Adighibe; Cameron Snell; Adrian L Harris; Kevin C Gatter; Francesco Pezzella
Journal:  Cancer Med       Date:  2013-07-08       Impact factor: 4.452

10.  Clinical significance of vasculogenic mimicry in human gliomas.

Authors:  Xiao-mei Liu; Qing-ping Zhang; Yong-gao Mu; Xiang-hen Zhang; Ke Sai; Jesse Chung-Sean Pang; Ho-Keung Ng; Zhong-ping Chen
Journal:  J Neurooncol       Date:  2011-04-30       Impact factor: 4.130

View more
  6 in total

Review 1.  Pathogenesis of non-functioning pituitary adenomas.

Authors:  Maria Chiara Zatelli
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

2.  Sprouting Angiogenesis in Human Pituitary Adenomas.

Authors:  Jie Zhou; Yaomin Hu; Wende Zhu; Chuansheng Nie; Wenxiu Zhao; Alexander T Faje; Kay E Labelle; Brooke Swearingen; Hang Lee; E Tessa Hedley-Whyte; Xun Zhang; Pamela S Jones; Karen K Miller; Anne Klibanski; Yunli Zhou; Roy J Soberman
Journal:  Front Oncol       Date:  2022-05-05       Impact factor: 5.738

3.  The Pituitary Tumors and Their Tumor-Specific Microenvironment.

Authors:  M M Kameda-Smith; J -Q Lu
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 4.  Overview of advances in vasculogenic mimicry - a potential target for tumor therapy.

Authors:  Hong Ge; Hui Luo
Journal:  Cancer Manag Res       Date:  2018-08-02       Impact factor: 3.989

5.  GLUT3 expression in cystic change induced by hypoxia in pituitary adenomas.

Authors:  Tao Mei; Jianhe Zhang; Liangfeng Wei; Xingfeng Qi; Yiming Ma; Xianhua Liu; Shaohua Chen; Songyuan Li; Jianwu Wu; Shousen Wang
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

Review 6.  Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry.

Authors:  Xue Zhang; Jigang Zhang; Heming Zhou; Guorong Fan; Qin Li
Journal:  J Cancer       Date:  2019-10-18       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.